Call for Abstract

Scientific Program

10th International Conference on COPD and Lungs, will be organized around the theme “Innovative Study on COPD and clinical Research Issues”

Copd 2020 is comprised of 17 tracks and 48 sessions designed to offer comprehensive sessions that address current issues in Copd 2020.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Track 1:Lung Diseases

Lung Diseases are the absolute most basic medical condition in the world. Smoking, infections, and genetics are main cause for lung diseases. The lungs are a piece of mechanical assembly, growing and loosening up a great many occasions every day to get oxygen and remove carbon dioxide. Lung infection can result from part of the lung.

  • Track 1-1Asthma.
  • Track 1-2Cystic Fibrosis (CF)/ Bronchiectasis.
  • Track 1-3Lung cancer
  • Track 1-4Pleural effusion
  • Track 1-5Pneumonia

Track 2:Therapeutic Devices and Evaluation

The common lung function tests are Spirometry, Chest X-ray, CT scan, Arterial blood gas analysis, Ventilation perfusion scan, Endobronchial Ultrasound (EBUS), Exhaled Nitric Oxide Test, Methacholine Challenge Test and many more. 

Track 3:Respiratory Infections

Respiratory Tract infection (RTI) includes various infectious diseases of the respiratory tract. An infection of this type classified as upper respiratory tract infection (URI or URTI) or a lower respiratory tract infection (LRI or LRTI).
Upper respiratory tract infections include pharyngitis, laryngitis, tonsillitis, and certain types of influenza, sinusitis, otitis media and the common cold. Lower respiratory tract infections include bronchitis and pneumonia.
  • Track 3-1Lower respiratory tract infection
  • Track 3-2Upper respiratory tract infection

Track 4:Pulmonary, Critical care and Sleep

Pulmonary, Critical care and Sleep includes various diseases related pulmonary diseases, sleep disorders and its critical care

  • Track 4-1Pulmonary arterial hypertension (PAH)
  • Track 4-2Pulmonary hypertension due to left-sided heart disease

Track 5:Pulmonary Hypertension

Pulmonary hypertension is a kind of hypertension that influences the supply routes in your lungs and the right side of your heart.

  • Track 5-1pulmonary arterial hypertension
  • Track 5-2pulmonary hypertension due to blood clots in the lungs
  • Track 5-3pulmonary hypertension due to left heart disease
  • Track 5-4pulmonary hypertension due to lung disease and/or chronic hypoxia.

Track 6:Prevention of COPD

COPD can be prevented by avoiding tobacco exposure and toxic fumes. Vaccination against viral influenza and Streptococcus pneumoniae is prescribed.

  • Track 6-1Avoid exposure
  • Track 6-2Help fight for clean air

Track 7:Pathogenesis of COPD

Pathologic changes in chronic obstructive pulmonary disease (COPD) happen in the large (central) airway routes, the little (peripheral) bronchioles, and the lung parenchyma. Most instances of COPD are the consequence of introduction to noxious stimuli,, regularly tobacco smoke. The normal inflammatory response is enhanced in people inclined to COPD advancement. Increased quantities of activated polymorphonuclear leukocytes and macrophages discharge elastases in a way that can't be neutralized viably by antiproteases, bringing about lung destruction.

  • Track 7-1Chronic bronchitis
  • Track 7-2Emphysema
  • Track 7-3Refractory asthma

Track 8:Occupational & Environmental lung Disease

Occupational & Environmental lung diseases are group of diseases caused by the inhalation of dust, chemicals, or proteins. The severity of the disease is identified with the material inhaled and the intensity of exposure. Some of the Occupational Lung diseases are Asthma, Bronchiolitis Obliterans, COPD, Hypersensitivity Pneumonitis, Lung Cancer, Mesothelioma, Pneumoconiosis. Some of the Environmental lung diseases caused by Arsenic, Asbestos, BCME, Beryllium, Cadmium, Chromium, Coal dust, Diesel exhaust, Indium lung, Nickel, Silica and Tobacco smoke etc.

Track 9:Lung Transplantation

A lung transplant expels an individual's diseased lung and replaces it with a healthy one. The healthy lung originates from a benefactor who has died. Lung transplants are utilized for individuals who are probably going to die from lung diseases within 1 to 2 years. Their conditions are severe to different medications, for example, drugs or breathing gadgets, no longer work. Lung transplants regularly are utilized to treat individuals who have serious COPD, Cystic fibrosis, Idiopathic pulmonary fibrosis, Alpha-1 antitrypsin inadequacy and pulmonary hypertension.

  • Track 9-1Single-lung
  • Track 9-2Double-lung
  • Track 9-3Heart–lung

Track 10:Asthma and allergy

Allergy occurs when the immune system in an individual responds to allergens which are substances in condition that don't cause issues for many people. This response prompts irritation (redness and swelling) that causes unfavorably susceptible conditions, which can influence different parts  of the body, for example, hypersensitive rhinitis, skin inflammation or urticaria, hypersensitivity and asthma. Individuals with asthma experience a narrowing of the airway routes in the lungs, which obstructs the stream of air into and out of the lungs.

  • Track 10-1Be short of breath
  • Track 10-2Breathe quickly
  • Track 10-3Dust mites.
  • Track 10-4Feel your chest get tight

Track 11:Lung cancer

Lung cancer is a condition where cells multiply in the lungs uncontrollably. This causes the development of tumors that decrease an individual's capacity to breathe. This development can spread beyond the lung by the process of metastasis into close-by tissue or different parts of the body.

  • Track 11-1Adenocarcinoma
  • Track 11-2Large cell carcinoma
  • Track 11-3Squamous cell cancer
  • Track 11-4Undifferentiated non small cell lung cancer

Track 12:Interstitial Lung Disease

Interstitial Lung Disease is a general class that includes a wide range of lung conditions. All interstitial lung diseases influence the interstitium, a part of the lungs' anatomic structure.

  • Track 12-1Hypersensitivity pneumonitis
  • Track 12-2Idiopathic pulmonary fibrosis
  • Track 12-3Interstitial pneumonia
  • Track 12-4Nonspecific interstitial pneumonitis

Track 13:Epidemiology of COPD

Chronic obstructive pulmonary disease (COPD) is a main source of world-wide mortality and disability. On average ∼5– 15% of adults in industrialized nations have COPD characterized by spirometry. In 1990, COPD was determined as at the twelfth position worldwide reason for consolidated mortality and disability but it is expected to be the fifth cause by 2020COPD has an chronic long-lasting course with irreversible decrease of forced expiratory volume in one second (FEV1), increasing nearness of dyspnoea and other respiratory manifestations, and dynamic decay of wellbeing status. After analysis the 10-yr survival rate is ∼50% with more than 33% of patients dying because of respiratory inadequacy.

Track 14:COPD Management

COPD management plan includes
 
(1) evaluate and screen disease
 
(2) reduce risk factors
 
(3) manage stable COPD
 
(4) manage exacerbations.
  • Track 14-1assess and monitor disease
  • Track 14-2manage exacerbations
  • Track 14-3manage stable COPD
  • Track 14-4reduce risk factors

Track 15:COPD Exacerbations

Exacerbations drive wellbeing status and contribute to disease enhancement and exacerbation prevention is a key objective for treatment of COPD. Most of COPD exacerbations are activated by respiratory viral and bacterial infections.
 
  • Track 15-1Type 1 exacerbations
  • Track 15-2Type 2 exacerbations
  • Track 15-3Type 3 exacerbations

Track 16:CO-Morbidities in COPD

Comorbidities like heart disease, hypertension, osteoporosis, diabetes mellitus and psychological disorders are generally reported in patients with chronic obstructive pulmonary disease (COPD). Tobacco smoking is a hazard factor for huge numbers of these comorbidities just as for COPD, making it hard to draw conclusions about the connection among COPD and these comorbidities.

Track 17:Cardiovascular Risk and COPD

Individuals with chronic obstructive pulmonary disease(COPD) have a higher inclination and mortality from cardiovascular diseases, and diminishing cardiovascular mortality is the target region for decreasing mortality in individuals with COPD.

  • Track 17-1High LDL or low HDL cholesterol levels
  • Track 17-2Lack of exercise
  • Track 17-3Obesity
  • Track 17-4Smoking